Background Risk factors for acquisition of vancomycin-resistant Enterococcus (VRE) include
immunosuppression, antibiotic exposure, indwelling catheters, and manipulation of the …

We retrospectively studied 16 (3 colonization and 13 infections) early post-liver transplant
(≤ 60-day after transplantation) patients with vancomycin-resistant enterococci (VRE) …

Background Infection with vancomycin‐resistant Enterococcus (VRE) in liver transplant
recipients (LTR) has been associated with extended hospital stays, increased readmission …

Abstract Background Vancomycin‐resistant Enterococcus (VRE)‐colonized liver
transplantation (LT) recipients have increased post‐LT morbidity, mortality, and higher rates …

Background Infections caused by vancomycin‐resistant Enterococcus faecium (VRE) are a
major cause of morbidity and mortality in the liver transplant population. Daptomycin (DAP) …

Abstract Background Vancomycin‐resistant Enterococcus faecium (VRE) infections are
common in liver transplant recipients (LTR s). Daptomycin (DAP) is an important treatment …

Background Vancomycin‐resistant enterococci (VRE) colonization is common in liver
transplant recipients and has been associated with worse posttransplant outcomes. Methods …

Background: Liver transplant recipients are at high risk for multi‐drug resistant infections
because of broad‐spectrum antibiotic and immunosuppression. This study evaluates the …

Background Enterococcus species are a common cause of bacteremia in liver transplant
recipients. Vancomycin-resistant enterococci (VRE) have become an important cause of …

Background Vancomycin‐resistant enterococci (VRE) colonization in nonliver solid organ
transplantation (SOT) is poorly defined. Infection control management of these patients is …